Shree Ganesh Remedies Ltd

Shree Ganesh Remedies Ltd | Sector: Pharmaceuticals | ISIN: INE414Y01015

Trade

Corporate Actions

24 Jan , 2023

12:00 AM

Rights

View Details

19 Jan , 2023

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

10 Jan , 2023

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

10 Jan , 2023

12:00 AM

Results

View Details

15 Oct , 2022

12:00 AM

Results

View Details

15 Oct , 2022

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

13 Sep , 2022

12:00 AM

AGM

Announcement date: 13 Sep , 2022

View Details

06 May , 2022

12:00 AM

Dividend

Dividend amount: 0.5
Announcement date: 06 May , 2022

View Details

04 Jul , 2022

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

04 Jul , 2022

12:00 AM

Results

View Details

27 Apr , 2022

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

13 Sep , 2022

12:00 AM

BookCloser

View Details

Shree Ganesh Remedies Ltd News and Update

Power Grid Corporation acquires Khavda II-C Transmission Ltd

6 hours ago |
4:02 PM

Acquisition done for Rs 18.45 crore.

Hindustan Zinc's dividend payments may ease Vedanta's debt repayment challe...

IIFL News Service |
9 hours ago |
4:02 PM

Govt to sell up to 3.5% stake in HAL

IIFL News Service |
9 hours ago |
4:02 PM

Reliance re-launches auction for sale of natural gas from eastern block

20 March, 2023 |
3:58 PM

FINANCIALS

Select Period:

Particulars ( Rupees In Crores.)	--	--	--	--
Gross Sales	--	--	--	--
Excise Duty	--	--	--	--
Net Sales	--	--	--	--
Other Operating Income	--	--	--	--
Other Income	--	--	--	--
Total Income	--	--	--	--
Total Expenditure **	--	--	--	--
PBIDT	--	--	--	--
Interest	--	--	--	--
PBDT	--	--	--	--
Depreciation	--	--	--	--
Minority Interest Before NP	--	--	--	--
Tax	--	--	--	--
Deferred Tax	--	--	--	--
Reported Profit After Tax	--	--	--	--
Minority Interest After NP	--	--	--	--
Net Profit after Minority Interest	--	--	--	--
Extra-ordinary Items	--	--	--	--
Adjusted Profit After Extra-ordinary item	--	--	--	--
EPS (Unit Curr.)	--	--	--	--
Book Value (Unit Curr.)	--	--	--	--
Dividend (%)	--	--	--	--
Equity	--	--	--	--
Public Shareholding (Number)	--	--	--	--
Public Shareholding (%)	--	--	--	--
Pledged/Encumbered - No. of Shares	--	--	--	--
Pledged/Encumbered - % in Total Promoters Holding	--	--	--	--
Pledged/Encumbered - % in Total Equity	--	--	--	--
Non Encumbered - No. of Shares	--	--	--	--
Non Encumbered - % in Total Promoters Holding	--	--	--	--
Non Encumbered - % in Total Equity	--	--	--	--
PBIDTM(%)	--	--	--	--
PBDTM(%)	--	--	--	--
PATM(%)	--	--	--	--

No Record Found

Particulars ( Rupees In Crores.)	--	--	--	--
Gross Sales	--	--	--	--
Excise Duty	--	--	--	--
Net Sales	--	--	--	--
Other Operating Income	--	--	--	--
Other Income	--	--	--	--
Total Income	--	--	--	--
Total Expenditure **	--	--	--	--
PBIDT	--	--	--	--
Interest	--	--	--	--
PBDT	--	--	--	--
Depreciation	--	--	--	--
Minority Interest Before NP	--	--	--	--
Tax	--	--	--	--
Deferred Tax	--	--	--	--
Reported Profit After Tax	--	--	--	--
Minority Interest After NP	--	--	--	--
Net Profit after Minority Interest	--	--	--	--
Extra-ordinary Items	--	--	--	--
Adjusted Profit After Extra-ordinary item	--	--	--	--
EPS (Unit Curr.)	--	--	--	--
Book Value (Unit Curr.)	--	--	--	--
Dividend (%)	--	--	--	--
Equity	--	--	--	--
Public Shareholding (Number)	--	--	--	--
Public Shareholding (%)	--	--	--	--
Pledged/Encumbered - No. of Shares	--	--	--	--
Pledged/Encumbered - % in Total Promoters Holding	--	--	--	--
Pledged/Encumbered - % in Total Equity	--	--	--	--
Non Encumbered - No. of Shares	--	--	--	--
Non Encumbered - % in Total Promoters Holding	--	--	--	--
Non Encumbered - % in Total Equity	--	--	--	--
PBIDTM(%)	--	--	--	--
PBDTM(%)	--	--	--	--
PATM(%)	--	--	--	--

No Record Found

PEER COMPARISON

Company Name	LTP (₹)	P/E (%)	Mkt.Cap (₹Cr.)	NP Qtr (₹Cr.)	Div.Yield (%)	Sales Qtr (₹.Cr)	Book Value (₹)
Sun Pharmaceuticals Industries Ltd	976.00	89.91	2,33,203.36	486.73	1.03	4,549.90	108.48
Dr Reddys Laboratories Ltd	4,447.95	31.58	74,537.97	324.60	0.67	3,879.60	1,156.21
Divis Laboratories Ltd	2,804.05	31.22	74,065.73	310.90	1.08	1,689.83	454.85
Cipla Ltd	869.50	25.19	69,689.38	678.52	0.58	3,541.16	291.76
Torrent Pharmaceuticals Ltd	1,529.10	49.01	51,408.17	229.00	1.58	1,826.00	191.38

Figures of Market Capital(Mar Cap), Quaterly Net Profit(NP Qtr) and Quaterly Sales(Sales Qtr) are in ₹ Cr.

MORE ABOUT Shree Ganesh Remedies Ltd

Chandulal M Kothia
Chairman & Managing Director

Gunjan Chandulal Kothia
Whole-time Director

Jayesh Kishanlal Savjani
Independent Director

Priyam Surendra Shah
Independent Director

Jigisha Jivrajbhai Kakadiya
Independent Director

Parth Chandulal Kothia
Additional Director

Sunnykumar Jitendrabhai Narwani
Company Secretary

Summary

Summary Info Not Found

Reports by Shree Ganesh Remedies Ltd
Annual ReportAuditors Report
Management DiscussionDirectors Report

Reports by Shree Ganesh Remedies Ltd
Investor PresentationConference Call TranscriptConference Call Audio

Shree Ganesh Remedies Ltd

KEY RATIOS

Corporate Actions

SHAREHOLDING SNAPSHOT 23 March , 2023 | 07:05 PM

Knowledge Center

Shree Ganesh Remedies Ltd News and Update

FINANCIALS

Select Period:

QUICK LINKS

Quarterly Result

Half Yearly Result

Nine Monthly Result

Annual Result

PEER COMPARISON

MORE ABOUT Shree Ganesh Remedies Ltd

Chandulal M Kothia

Gunjan Chandulal Kothia

Jayesh Kishanlal Savjani

Priyam Surendra Shah

Jigisha Jivrajbhai Kakadiya

Parth Chandulal Kothia

Sunnykumar Jitendrabhai Narwani

Summary

IIFL Customer Care Number

IIFL Securities Support Whatsapp Number

Download The App Now

IIFL Customer Care Number

IIFL Securities Support Whatsapp Number

Download The App Now

SHAREHOLDING SNAPSHOT
23 March , 2023 | 07:05 PM